发明申请
- 专利标题： GLYCINE B ANTAGONISTS
- 专利标题（中）： 糖蛋白B拮抗剂
-
申请号： US13375954申请日： 2010-06-04
-
公开(公告)号： US20120220577A1公开(公告)日： 2012-08-30
- 发明人: Markus Henrich , Angela Hansen , Jens Nagel , Valerjans Kauss , Jevgenijs Rozhkovs , Ginta Grunsteine , Dina Trifanova
- 申请人： Markus Henrich , Angela Hansen , Jens Nagel , Valerjans Kauss , Jevgenijs Rozhkovs , Ginta Grunsteine , Dina Trifanova
- 专利权人： Merz Pharma GmbH & Co KgaA
- 当前专利权人： Merz Pharma GmbH & Co KgaA
- 优先权： EP09007401.4 20090604
- 国际申请： PCT/EP2010/003383 WO 20100604
- 主分类号： A61K31/19
- IPC分类号： A61K31/19 ; C07C271/22 ; A61K31/27 ; C07D211/60 ; A61K31/445 ; C07D207/08 ; A61K31/40 ; C07D215/14 ; A61K31/47 ; C07D265/36 ; A61K31/538 ; C07D265/30 ; A61K31/5375 ; C07D257/04 ; A61K31/41 ; A61P29/00 ; A61P25/02 ; C07C63/34
摘要：
The invention relates to naphthalene derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.